1. MicroRNA-550a is associated with muscle system conferring poorer survival for esophageal cancer
   Housong Hong et al, 2019, Bioscience Reports CrossRef
2. Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
   Dechao Zhan et al, 2022, Emergency Medicine International CrossRef
3. miR-655: A promising regulator with therapeutic potential
   Hongxiang Li et al, 2020, Gene CrossRef
4. MicroRNA‑655 inhibits cell proliferation and invasion in epithelial ovarian cancer by directly targeting vascular endothelial growth factor
   Ziling Zhao et al, 2018, Molecular Medicine Reports CrossRef
5. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles carrying miR-655-3p inhibit the development of esophageal cancer by regulating the expression of HIF-1α via a LMO4/HDAC2-dependent mechanism
   Mingjiu Chen et al, 2023, Cell Biology and Toxicology CrossRef
6. Diagnostic biomarker and therapeutic target applications of miR‐326 in cancers: A systematic review
   Golamreza Jadideslam et al, 2019, Journal of Cellular Physiology CrossRef
7. Dysregulated Expression of miR-146a and Its Associated Immune Effectors in Peripheral Blood Mononuclear Cells of Esophageal Carcinoma Patients
   Ziba Nariman-Saleh-Fam et al, 2022, Immunological Investigations CrossRef